NASDAQ : ISRG
$0.36 (0.1%)
| Source | Headline |
|---|---|
|
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. zacks.com - 2026-07-31 10:01:52 |
|
BankChampaign National Association Invests $908,000 in Intuitive Surgical, Inc. $ISRG
BankChampaign National Association purchased a new stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,969 shares of the medical equipment provider's stock, valued at approximately $908,000. Other large investors also recently defenseworld.net - 2026-07-31 04:03:38 |
|
Is ISRG Winning the Next Phase of Robotic Surgery Beyond Urology?
ISRG is expanding robotic surgery beyond urology as general surgery and newer specialties gain traction, creating fresh avenues for long-term procedure growth. zacks.com - 2026-07-30 13:41:11 |
|
This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run
Medtronic could finally be on the cusp of a long-awaited turnaround. fool.com - 2026-07-29 10:44:59 |
|
Amundi Acquires 193,096 Shares of Intuitive Surgical, Inc. $ISRG
Amundi lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 8.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,428,356 shares of the medical equipment provider's stock after buying an additional 193,096 shares during the period. defenseworld.net - 2026-07-29 03:47:44 |
|
ISRG Q2 Earnings Call Signals Durable Demand & U.S. Caution
ISRG pairs durable platform demand and higher margin guidance with caution on softer U.S. procedure growth and deferred care. zacks.com - 2026-07-28 11:01:16 |
|
Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685
Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) trades at $356.83, while the average Wall Street price target sits at $484.40. 247wallst.com - 2026-07-28 09:47:15 |
|
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made the biggest moves today. 247wallst.com - 2026-07-28 07:42:49 |
|
Here's Exactly Why Wall Street Thinks Intuitive Surgical Stock Could Soar 102% Over the Next 12 Months
The da Vinci 5 is driving growth throughout the business. This traditionally expensive stock has suddenly become a bargain. fool.com - 2026-07-28 07:30:00 |
|
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options
Intuitive today announced a collaboration with Deion “Coach Prime” Sanders to help increase patient awareness and understanding of surgical options. globenewswire.com - 2026-07-27 09:15:00 |
|
Intuitive Surgical, Inc. $ISRG Shares Bought by Bank of Nova Scotia
Bank of Nova Scotia boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 13.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 618,138 shares of the medical equipment provider's stock after buying an additional 75,579 shares during the quarter. defenseworld.net - 2026-07-24 04:03:55 |
|
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
There are plenty of reasons to love these companies. fool.com - 2026-07-24 00:30:00 |
|
ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now?
ISRG's expanding robotic surgery ecosystem and innovation pipeline give it an edge over Abbott for investors seeking stronger long-term MedTech growth. zacks.com - 2026-07-23 15:11:05 |
|
Why Intuitive Surgical, Inc. (ISRG) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 2026-07-23 10:46:03 |
|
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. zacks.com - 2026-07-23 10:31:26 |
|
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. zacks.com - 2026-07-23 09:25:12 |
|
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
SUNNYVALE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, will outline its vision for how artificial intelligence (AI) can help shape the future of surgical care and address key healthcare challenges at the Society of Robotic Surgery's (SRS) annual conference in Hollywood, Florida. globenewswire.com - 2026-07-23 09:05:00 |
|
Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise
ISRG's strong procedure growth, recurring revenue and cash position support its case, but tariffs, mix shifts and placement risks cloud the outlook. zacks.com - 2026-07-22 13:06:12 |
|
ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure
ISRG's growth is fueled by robotic surgery, Ion lung biopsy and AI tools, while tariffs, product mix and softer demand pressure margins. zacks.com - 2026-07-22 13:06:08 |
|
ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue
Intuitive Surgical's growth rests on da Vinci 5, Ion, SP and digital tools as recurring revenue rises and procedure risks persist. zacks.com - 2026-07-22 13:06:05 |
|
Can ISRG Maintain Its Premium Valuation Amid Slower Procedure Growth?
Intuitive Surgical's valuation has eased as U.S. procedure growth slows, but margin gains, AI software expansion and global growth could support its premium. zacks.com - 2026-07-22 12:10:38 |
|
Is Intuitive Surgical a Buy After Its Latest Earnings Report?
At first glance, its numbers were impressive. fool.com - 2026-07-21 15:51:00 |
|
Intuitive Surgical Stock Is Trading at Multi-Year Lows: Is It a Bargain Buy?
Shares of Intuitive Surgical are down nearly 40% this year. fool.com - 2026-07-21 08:29:50 |
|
Intuitive Surgical, Inc. $ISRG Shares Purchased by Andra AP fonden
Andra AP fonden grew its position in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 139.7% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 50,050 shares of the medical equipment provider's stock after purchasing an additional 29,168 shares during the period. defenseworld.net - 2026-07-21 03:50:03 |
|
AlTi Global Inc. Purchases 2,356 Shares of Intuitive Surgical, Inc. $ISRG
AlTi Global Inc. grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 353.2% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,023 shares of the medical equipment provider's stock after purchasing an additional 2,356 shares during the quarter. defenseworld.net - 2026-07-21 03:13:51 |
|
3 Reasons Growth Investors Will Love Intuitive Surgical (ISRG)
Intuitive Surgical (ISRG) possesses solid growth attributes, which could help it handily outperform the market. zacks.com - 2026-07-20 13:46:19 |
|
Down 15% in 4 Weeks, Here's Why You Should You Buy the Dip in Intuitive Surgical (ISRG)
Intuitive Surgical (ISRG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. zacks.com - 2026-07-20 10:36:05 |
|
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. zacks.com - 2026-07-20 10:01:13 |
|
Intuitive Surgical: The Correction Has Done The Work The Fundamentals Could Not
Intuitive Surgical, Inc. has declined ~38% since my previous Hold, driven by valuation concerns and recent structural headwinds. Despite ISRG's Q2 2026 earnings growth, margin expansion, and raised guidance, markets reacted to a slowdown in U.S. procedure growth. Pressures stem from expiring ACA subsidies impacting elective surgeries and weight loss drugs reducing bariatric procedure demand. seekingalpha.com - 2026-07-20 08:46:49 |
|
Why Intuitive Surgical Stock Dropped This Week
Intuitive Surgical posted strong sales and profit gains in the second quarter. But management issued a tepid forecast for the rest of 2026. fool.com - 2026-07-18 17:21:17 |
|
Why Intuitive Surgical's Strong Quarter Still Spooked Investors
Intuitive Surgical TodayISRGIntuitive Surgical$345.42 -56.91 (-14.15%) As of 07/17/2026 04:00 PM Eastern52-Week Range$344.55▼$603.88P/E Ratio39.57Price Target$523.46Add to WatchlistIntuitive Surgical NASDAQ: ISRG was part of the artificial intelligence (AI)/robotics trade before it became mainstream. marketbeat.com - 2026-07-18 08:15:27 |
|
Intuitive Surgical Q2 Earnings Call Highlights
Intuitive Surgical (NASDAQ: ISRG) reported a solid second quarter of 2026, with management pointing to continued global adoption of its da Vinci, da Vinci SP and Ion platforms, even as U.S. procedure growth moderated and China remained challenging. Chief Executive Officer Dave Rosa said total procedures increased 16% in the quarter, driven by 15% growth in defenseworld.net - 2026-07-18 07:24:45 |
|
Intuitive Surgical Is Getting Punished For No Good Reason
Intuitive Surgical remains a buy despite a nearly 30% stock decline and post-earnings volatility. Adoption metrics are resilient, with strong system placements and installed base growth offsetting softer U.S. procedure growth. Profitability improved: Q2 non-GAAP gross margin expanded to 70%, operating margin to 42.1%, and EPS beat by $0.30. seekingalpha.com - 2026-07-18 06:09:58 |
|
Allspring Global Investments Holdings LLC Cuts Stake in Intuitive Surgical, Inc. $ISRG
Allspring Global Investments Holdings LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 5.7% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 137,212 shares of the medical equipment provider's stock after selling 8,356 shares during the period. Allspring defenseworld.net - 2026-07-18 03:11:14 |
|
Intuitive Surgical Q2: The Market Is Missing The Bigger Picture
Intuitive Surgical, Inc. remains a compelling long-term compounder, with operational improvements and robust growth prospects despite recent market headwinds. ISRG delivered solid Q2 results: revenue and EPS beat estimates, da Vinci procedures grew 20%, and gross margin reached 70%, reinforcing ISRG's strong positioning. Current valuation near a 5-year low—~35x forward earnings—offers a more attractive entry point, with multiple compression creating a margin of safety. seekingalpha.com - 2026-07-17 19:31:38 |
|
Why Intuitive Surgical Stock Plunged Today
Intuitive Surgical (ISRG) shares plummeted Friday after the maker of robotic surgical tools failed to raise the outlook for its flagship product despite better-than-expected second-quarter results. investopedia.com - 2026-07-17 17:00:45 |
|
ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth
ISRG beats second-quarter earnings and revenue estimates, but shares fall after hours as procedure growth slows sequentially despite strong placements. zacks.com - 2026-07-17 15:21:05 |
|
Intuitive Surgical Stock Sinks to 52-Week Low - Here's Why
Intuitive Surgical Inc. (NASDAQ:ISRG) stock fell sharply Friday after the company reaffirmed its 2026 da Vinci procedure growth outlook but flagged slowing U.S. procedure trends and insurance-related headwinds that weighed on investor sentiment. benzinga.com - 2026-07-17 14:15:42 |
|
3 Medical Instrument Stocks Betting on GenAI to Ease Industry Hurdles
GenAI creates new opportunities for ISRG, ALC and LIVN, even as regulatory, inflation and industry headwinds continue to pressure MedTech. zacks.com - 2026-07-17 11:26:09 |
|
Intuitive Surgical shares fall as procedure growth slows despite Q2 earnings beat
Intuitive Surgical (NASDAQ: ISRG) shares fell about 11% on Friday after the robotic surgery company reported second-quarter results that topped Wall Street expectations but disappointed investors with slower US procedure growth and a cautious full-year outlook. The company reported second quarter revenue of $2.89 billion, up 19% from a year earlier and above analysts' consensus estimate of $2.82 billion. proactiveinvestors.com - 2026-07-17 10:44:09 |
|
Friday's Morning Movers: SPCX Scrubs Test Flights, AAPL Upgrade, ISRG Earnings
Diane King Hall discusses Intuitive Surgical (ISRG) earnings, explaining how GLP-1 trends have hit the company. She also talks about SpaceX (SPCX) shares coming back to Earth after scrubbing Starship's test flight, and HSBC's upgrade on Apple (AAPL) to buy from hold. youtube.com - 2026-07-17 10:30:11 |
|
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq 100 futures falling around 2% on Friday. benzinga.com - 2026-07-17 08:02:06 |
|
These Analysts Slash Their Forecasts On Intuitive Surgical Following Q2 Earnings
Intuitive Surgical Inc. (NASDAQ:ISRG) posted better-than-expected second-quarter results after Thursday's closing bell. benzinga.com - 2026-07-17 07:38:20 |
|
Intuitive Surgical falls as Obamacare concerns rekindle medtech demand debate
Intuitive Surgical shares fell more than 12% before the bell on Friday after it maintained its global growth forecast for procedures performed with its da Vinci surgical robots and warned that changes to some insurance plans could hurt demand. reuters.com - 2026-07-17 07:22:24 |
|
Intuitive Surgical stock sinks despite earnings beat on 2026 procedure growth outlook
Shares of Intuitive Surgical tumbled about 12% in premarket trading on Friday after the robotic surgery company issued a full-year procedure growth outlook that fell short of investor expectations, overshadowing stronger-than-expected second-quarter earnings and revenue. The maker of the da Vinci robotic surgery platform reported adjusted earnings of $2.80 per share for the quarter, comfortably ahead of analysts' estimates of $2.51. invezz.com - 2026-07-17 07:10:58 |
|
Compared to Estimates, Intuitive Surgical (ISRG) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Intuitive Surgical (ISRG) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2026-07-16 22:31:04 |
|
Should You Buy Intuitive Surgical With the Stock Down 35%? Here's What History Says.
Intuitive Surgical makes and supports the da Vinci surgical robot system. The company's flywheel is the sale of parts and services. fool.com - 2026-07-16 22:15:00 |
|
Intuitive Surgical, Inc. (ISRG) Q2 2026 Earnings Call Transcript
Intuitive Surgical, Inc. (ISRG) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-07-16 20:16:17 |
|
Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Top Estimates
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.48 per share. This compares to earnings of $2.19 per share a year ago. zacks.com - 2026-07-16 18:15:17 |
|
Intuitive Surgical Q2 Earnings Call Highlights
Intuitive Surgical NASDAQ: ISRG reported a solid second quarter of 2026, with management pointing to continued global adoption of its da Vinci, da Vinci SP and Ion platforms, even as U.S. procedure growth moderated and China remained challenging. marketbeat.com - 2026-07-16 18:04:09 |